ScholarIQanswers from OpenAlex

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer

PaperCitations, authors & open-access status

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer have?

ScholarIQcitation count

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer has 292 citations in the OpenAlex counts ScholarIQ stores.

When was Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer published?

ScholarIQyear

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer has 2021 year in the ScholarIQ index.

What is the open-access status of Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer?

ScholarIQoa status

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer has gold oa status in the ScholarIQ index.

What is the DOI of Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer?

ScholarIQdoi

The DOI for Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer is on the source record.

What is the PMID of Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer?

ScholarIQpmid

The PMID for Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer is on the source record.

What is the OpenAlex record for Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer?

ScholarIQopenalex

The OpenAlex for Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial